These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38898395)

  • 1. Exchange transfusion combined with artesunate (ET-AS) as a safe and effective therapy in severe P. falciparum malaria: a case series.
    Zhang J; Chen L; Zhang M; Yao M; Ren S; Liu H; Min Y; Jia Y; Tao Y; Zhang H
    BMC Infect Dis; 2024 Jun; 24(1):603. PubMed ID: 38898395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria.
    Kreeftmeijer-Vegter AR; Melo Mde M; de Vries PJ; Koelewijn R; van Hellemond JJ; van Genderen PJ
    Malar J; 2013 Mar; 12():115. PubMed ID: 23537187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of red blood cell exchange for severe imported malaria in the artesunate era: a retrospective cohort study in a referral centre.
    Calvo-Cano A; Gómez-Junyent J; Lozano M; Castro P; Cid J; Nicolás JM; Quintó L; Martin M; Muñoz J; Gascon J
    Malar J; 2016 Apr; 15():216. PubMed ID: 27075988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
    Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
    Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
    Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.
    Congpuong K; Bualombai P; Banmairuroi V; Na-Bangchang K
    Malar J; 2010 Feb; 9():43. PubMed ID: 20132537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated
    Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S
    Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.
    Tangpukdee N; Krudsood S; Srivilairit S; Phophak N; Chonsawat P; Yanpanich W; Kano S; Wilairatana P
    Korean J Parasitol; 2008 Jun; 46(2):65-70. PubMed ID: 18552540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol.
    van Genderen PJ; Hesselink DA; Bezemer JM; Wismans PJ; Overbosch D
    Transfusion; 2010 Apr; 50(4):787-94. PubMed ID: 19951317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.